Hygeia Healthcare Holdings Management
Management criteria checks 4/4
Hygeia Healthcare Holdings' CEO is Yiwen Zhu, appointed in Aug 2021, has a tenure of 3.25 years. total yearly compensation is CN¥2.49M, comprised of 24.1% salary and 75.9% bonuses, including company stock and options. directly owns 44.98% of the company’s shares, worth HK$4.58B. The average tenure of the management team and the board of directors is 3.8 years and 5 years respectively.
Key information
Yiwen Zhu
Chief executive officer
CN¥2.5m
Total compensation
| CEO salary percentage | 24.1% |
| CEO tenure | 3.3yrs |
| CEO ownership | 45.0% |
| Management average tenure | 3.8yrs |
| Board average tenure | 5yrs |
Recent management updates
Recent updates
We Think Hygeia Healthcare Holdings (HKG:6078) Can Stay On Top Of Its Debt
Nov 25
After Leaping 53% Hygeia Healthcare Holdings Co., Limited (HKG:6078) Shares Are Not Flying Under The Radar
Oct 02Hygeia Healthcare Holdings' (HKG:6078) Returns Have Hit A Wall
Sep 25Hygeia Healthcare Holdings Co., Limited (HKG:6078) Analysts Are Cutting Their Estimates: Here's What You Need To Know
Sep 02Hygeia Healthcare Holdings Co., Limited's (HKG:6078) Share Price Is Still Matching Investor Opinion Despite 26% Slump
Aug 03Shareholders May Be A Bit More Conservative With Hygeia Healthcare Holdings Co., Limited's (HKG:6078) CEO Compensation For Now
Jun 21Investors Will Want Hygeia Healthcare Holdings' (HKG:6078) Growth In ROCE To Persist
May 23Market Participants Recognise Hygeia Healthcare Holdings Co., Limited's (HKG:6078) Earnings Pushing Shares 28% Higher
May 06Is Hygeia Healthcare Holdings (HKG:6078) Using Too Much Debt?
Apr 24Hygeia Healthcare Holdings Co., Limited Just Missed EPS By 7.5%: Here's What Analysts Think Will Happen Next
Mar 29Hygeia Healthcare Holdings Co., Limited (HKG:6078) Shares Could Be 41% Below Their Intrinsic Value Estimate
Feb 27Hygeia Healthcare Holdings Co., Limited (HKG:6078) Stocks Pounded By 25% But Not Lagging Market On Growth Or Pricing
Jan 09Returns On Capital Are Showing Encouraging Signs At Hygeia Healthcare Holdings (HKG:6078)
Dec 04Is Hygeia Healthcare Holdings Co., Limited (HKG:6078) Trading At A 48% Discount?
Oct 23Does Hygeia Healthcare Holdings (HKG:6078) Deserve A Spot On Your Watchlist?
Sep 21There's Been No Shortage Of Growth Recently For Hygeia Healthcare Holdings' (HKG:6078) Returns On Capital
Aug 31Calculating The Fair Value Of Hygeia Healthcare Holdings Co., Limited (HKG:6078)
Jul 21Should You Be Adding Hygeia Healthcare Holdings (HKG:6078) To Your Watchlist Today?
Jun 14Does This Valuation Of Hygeia Healthcare Holdings Co., Limited (HKG:6078) Imply Investors Are Overpaying?
Apr 18Do Hygeia Healthcare Holdings' (HKG:6078) Earnings Warrant Your Attention?
Feb 21Investors Will Want Hygeia Healthcare Holdings' (HKG:6078) Growth In ROCE To Persist
Dec 03Hygeia Healthcare Holdings Co., Limited (HKG:6078) Shares Could Be 31% Below Their Intrinsic Value Estimate
Nov 02Hygeia Healthcare Holdings (HKG:6078) Is Doing The Right Things To Multiply Its Share Price
Aug 09Hygeia Healthcare Holdings (HKG:6078) Shareholders Will Want The ROCE Trajectory To Continue
May 02After Leaping 58% Hygeia Healthcare Holdings Co., Limited (HKG:6078) Shares Are Not Flying Under The Radar
Apr 13Investors Will Want Hygeia Healthcare Holdings' (HKG:6078) Growth In ROCE To Persist
Jan 11Are Investors Undervaluing Hygeia Healthcare Holdings Co., Limited (HKG:6078) By 21%?
Nov 23With EPS Growth And More, Hygeia Healthcare Holdings (HKG:6078) Is Interesting
Oct 28Hygeia Healthcare Holdings (HKG:6078) Shareholders Will Want The ROCE Trajectory To Continue
Sep 02A Look At The Intrinsic Value Of Hygeia Healthcare Holdings Co., Limited (HKG:6078)
Aug 20Here's Why We Think Hygeia Healthcare Holdings (HKG:6078) Is Well Worth Watching
Jul 20Hygeia Healthcare Holdings Co., Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Mar 31Hygeia Healthcare Holdings Co., Limited (HKG:6078) Insiders Increased Their Holdings
Mar 02Are Hygeia Healthcare Holdings Co., Limited (HKG:6078) Investors Paying Above The Intrinsic Value?
Jan 26
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | CN¥733m |
| Mar 31 2024 | n/a | n/a | CN¥708m |
| Dec 31 2023 | CN¥2m | CN¥600k | CN¥683m |
| Sep 30 2023 | n/a | n/a | CN¥635m |
| Jun 30 2023 | n/a | n/a | CN¥587m |
| Mar 31 2023 | n/a | n/a | CN¥532m |
| Dec 31 2022 | CN¥4m | CN¥492k | CN¥477m |
| Sep 30 2022 | n/a | n/a | CN¥472m |
| Jun 30 2022 | n/a | n/a | CN¥468m |
| Mar 31 2022 | n/a | n/a | CN¥455m |
| Dec 31 2021 | CN¥709k | CN¥239k | CN¥441m |
| Sep 30 2021 | n/a | n/a | CN¥403m |
| Jun 30 2021 | n/a | n/a | CN¥365m |
| Mar 31 2021 | n/a | n/a | CN¥268m |
| Dec 31 2020 | CN¥45k | CN¥37k | CN¥170m |
| Sep 30 2020 | n/a | n/a | CN¥100m |
| Jun 30 2020 | n/a | n/a | CN¥29m |
| Mar 31 2020 | n/a | n/a | CN¥35m |
| Dec 31 2019 | CN¥779k | CN¥684k | CN¥40m |
Compensation vs Market: Yiwen's total compensation ($USD344.51K) is about average for companies of similar size in the Hong Kong market ($USD481.65K).
Compensation vs Earnings: Yiwen's compensation has been consistent with company performance over the past year.
CEO
Yiwen Zhu (60 yo)
3.3yrs
Tenure
CN¥2,493,000
Compensation
Mr. Yiwen Zhu serves as Executive Director & Co-Chief Executive Officer of at Hygeia Healthcare Holdings Co., Limited since August 23, 2021. He serves as Chairman of the Board at Hygeia Healthcare Holdings...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & Co-CEO | 3.3yrs | CN¥2.49m | 44.98% HK$ 4.6b | |
| Co-CEO & Executive Director | 3.3yrs | CN¥1.54m | no data | |
| Director of Research & Development | 4.8yrs | CN¥1.51m | 0.0052% HK$ 526.6k | |
| Director of Radiotherapy Division & Executive Director | 3.9yrs | CN¥1.33m | no data | |
| Joint Company Secretary | no data | CN¥2.32m | 0.46% HK$ 46.6m | |
| Financial Director | no data | no data | no data | |
| Joint Company Secretary | 3.8yrs | no data | no data |
3.8yrs
Average Tenure
42yo
Average Age
Experienced Management: 6078's management team is considered experienced (3.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & Co-CEO | 3.7yrs | CN¥2.49m | 44.98% HK$ 4.6b | |
| Co-CEO & Executive Director | 5.4yrs | CN¥1.54m | no data | |
| Director of Research & Development | 4.8yrs | CN¥1.51m | 0.0052% HK$ 526.6k | |
| Director of Radiotherapy Division & Executive Director | 3.9yrs | CN¥1.33m | no data | |
| Joint Company Secretary | 6.2yrs | CN¥2.32m | 0.46% HK$ 46.6m | |
| Independent Non-Executive Director | 5.2yrs | CN¥240.00k | no data | |
| Independent Non-Executive Director | 2.5yrs | CN¥240.00k | no data | |
| Independent Non-Executive Director | 5.2yrs | CN¥240.00k | no data |
5.0yrs
Average Tenure
51yo
Average Age
Experienced Board: 6078's board of directors are considered experienced (5 years average tenure).